Results 151 to 160 of about 77,701 (209)

Prevalence of Beta Blocker Prescribing for Hypertension. [PDF]

J Pharm Technol
Skory BJ, Arko J, Terkawi L, Slusarz E, King O, Deokarran C, Glista K, Will M, Etemadi H, Brosch E, Wasowski E, Soric MM.   +11 more
europepmc   +1 more source

J-shape positive association between E/E' and recurrent atrial fibrillation after radio-frequency catheter ablation: A cohort study in China. [PDF]

Medicine (Baltimore)
Bai L, Zhao L, Li R, Cui X, Wang D, Zhou Y, Zhang J.   +6 more
europepmc   +1 more source

Diabetes Status Modifies the Association Between Cardiorespiratory Fitness and Coronary Heart Disease: A Cross-Sectional Study. [PDF]

J Diabetes
Wang L, Lu Y, Zhang H.
europepmc   +1 more source

SGLT2 inhibitors are associated with improved long-term survival in Takotsubo syndrome: insights from large-scale real-world data. [PDF]

Eur Heart J Cardiovasc Pharmacother
Rawish E, Lemmer F, Kurz K, Mezger M, Pätz T, Stiermaier T, Eitel I.   +6 more
europepmc   +1 more source

Effect of the angiotensin II type 1 receptor blocker candesartan on cardiovascular events

Journal of the American College of Cardiology, 2002
Kondo, Junichiro, Sone, Takahito, Tsubo, Hideyuki, Mukawa, Hiroaki, Morishima, Itsuro, Uesugi, Michitaka, Kosaka, Takashi, Yoshida, Tomohiro   +7 more
openaire   +1 more source

Repurposing Renin-Angiotensin System Drugs for the Treatment of Audiovestibular Disorders. [PDF]

J Clin Med
Podhajsky G, Marla KS, Marticoff AP, Nguyen K, Kempton T, Salehpour S, Duffy C, Bennion DM.   +7 more
europepmc   +1 more source

Methylene Blue Rescue Therapy for Vasoplegic Shock After Antihypertensive Drug Overdose. [PDF]

Am J Case Rep
Aqel YHI, Karayem MMJ, Rahhal A, Hasan Koya S, Abusal AM, George S.   +5 more
europepmc   +1 more source

Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry. [PDF]

Eur J Heart Fail
Inciardi RM, Volterrani M, Savarese G, Vaduganathan M, Oriecuia C, Lombardi CM, Gussago C, Agostoni P, Ameri P, Armentaro G, Arzilli C, Aspromonte N, Attanasio A, Badagliacca R, Barbieri L, Bocchino PP, Bursi F, Cameli M, Canonero M, Campodonico JS, Capovilla T, Carluccio E, Carugo S, Castiglione V, Catapano D, Cipriani M, Correale M, D'Amario D, De Caterina R, De Ferrari GM, D'Elia E, Di Odoardo L, Emdin M, Falco L, Ferrante G, Fornaro A, Fornaro P, Guastamiglio G, Guazzi M, Iacoviello M, Imazio M, Incaminato E, La Rovere MT, Leonardi S, Maccallini M, Mandoli GE, Masarone D, Masetti M, Mazzoni A, Mazzotta M, Merlo M, Moschini L, Novarese F, Palazzuoli A, Pastore MC, Patti G, Pedretti RFE, Pidello S, Piepoli MF, Pinto G, Potena L, Raineri C, Rubbo FM, Sabatino M, Salzano A, Sciacqua A, Senni M, Severino P, Sinagra G, Sposato B, Taddei S, Valleggi A, Vignati C, Vizza D, Specchia C, Rosano G, Metra M, OPTIPHARM‐HF investigators.   +77 more
europepmc   +1 more source

General practice organisational models and heart failure medication adherence: multi-level evidence from a regional cohort in Emilia-Romagna, Italy. [PDF]

Int J Qual Health Care
Palombarini J, Rosa S, Golinelli D, Avaldi VM, Vallicelli G, Fantini M, Fantini MP, Lenzi J.   +7 more
europepmc   +1 more source